Pulmonary Arterial Hypertension Market Report - Epidemiology Forecast to 2027 - ResearchAndMarkets.com

DUBLIN--()--The "Pulmonary Arterial Hypertension - Epidemiology Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Pulmonary Arterial Hypertension - Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pulmonary Arterial Hypertension in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Pulmonary Arterial Hypertension Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, sex-specific prevalent cases, and sub-type specific prevalent cases) scenario of Pulmonary Arterial Hypertension (PAH)in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to the report, the total number of prevalent population of Pulmonary Arterial Hypertension (PAH) was found to be more than 70,000 in 7MM, in the year 2016. Women account for 70% of the total prevalent cases.

Key Topics Covered:

1. Report Introduction

2. Pulmonary Arterial Hypertension (PAH): Overview

3. Epidemiology and Patient Population

4. Treatment Algorithm

5. Unmet Needs

6. Report Methodology

For more information about this report visit https://www.researchandmarkets.com/research/krpv7k/pulmonary?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs